The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126199202 12619920 2 F 2016 20160812 20160803 20160826 EXP US-SAOL THERAPEUTICS-2016SAO00302 SAOL THERAPEUTICS 44.50 YR F Y 0.00000 20160826 CN COUNTRY NOT SPECIFIED US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126199202 12619920 1 PS COMPOUNDED BACLOFEN BACLOFEN 1 297.39 ?G, DAY U U 20075 297.39 UG INJECTION QD
126199202 12619920 2 SS COMPOUNDED BACLOFEN BACLOFEN 1 299.83 ?G, DAY U U 20075 299.83 UG INJECTION QD
126199202 12619920 3 SS COMPOUNDED BACLOFEN BACLOFEN 1 Intrathecal 315.14 ?G, DAY U U 20075 315.14 UG INJECTION QD
126199202 12619920 4 SS COMPOUNDED BACLOFEN BACLOFEN 1 Intrathecal 420.2 ?G, DAY U U 20075 420.2 UG INJECTION QD
126199202 12619920 5 SS COMPOUNDED BACLOFEN BACLOFEN 1 U U 20075 INJECTION
126199202 12619920 6 SS MORPHINE MORPHINE 1 Intrathecal 5.948 MG, DAY 0 5.948 MG QD
126199202 12619920 7 SS MORPHINE MORPHINE 1 Intrathecal 5.997 MG, DAY 0 5.997 MG QD
126199202 12619920 8 SS MORPHINE MORPHINE 1 6.303 MG, DAY 0 6.303 MG QD
126199202 12619920 9 SS BUPIVACAINE. BUPIVACAINE 1 Intrathecal 7.930 MG, DAY 0 7.93 MG QD
126199202 12619920 10 SS BUPIVACAINE. BUPIVACAINE 1 7.995 ?G, DAY 0 7.995 UG QD
126199202 12619920 11 SS BUPIVACAINE. BUPIVACAINE 1 8.404 ?G, DAY 0 8.404 UG QD
126199202 12619920 12 SS BUPIVACAINE. BUPIVACAINE 1 Intrathecal 8.404 MG, DAY 0 8.404 MG QD
126199202 12619920 13 SS CLONIDINE. CLONIDINE 1 Intrathecal 39.65 ?G, DAY 0 39.65 UG QD
126199202 12619920 14 SS CLONIDINE. CLONIDINE 1 Intrathecal 39.98 ?G, DAY 0 39.98 UG QD
126199202 12619920 15 SS CLONIDINE. CLONIDINE 1 Intrathecal 42.02 ?G, DAY 0 42.2 UG QD
126199202 12619920 16 SS CLONIDINE. CLONIDINE 1 42.02 ?G, DAY 0 42.2 UG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126199202 12619920 1 Lumbar radiculopathy
126199202 12619920 2 Pain
126199202 12619920 4 Lumbar radiculopathy
126199202 12619920 5 Pain

Outcome of event

Event ID CASEID OUTC COD
126199202 12619920 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126199202 12619920 Device dislocation
126199202 12619920 Drug withdrawal syndrome
126199202 12619920 Hypoaesthesia
126199202 12619920 Impaired healing
126199202 12619920 Medical device site discharge
126199202 12619920 Medical device site erythema
126199202 12619920 Medical device site infection
126199202 12619920 Medical device site pain
126199202 12619920 Medical device site vesicles

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126199202 12619920 1 20150924 0
126199202 12619920 2 20160120 0
126199202 12619920 3 20160218 0
126199202 12619920 4 20160414 0
126199202 12619920 6 20150924 0
126199202 12619920 7 20160120 0
126199202 12619920 8 20160218 0
126199202 12619920 9 20150924 0
126199202 12619920 10 20160120 0
126199202 12619920 11 20160218 0
126199202 12619920 12 20160414 0
126199202 12619920 13 20150924 0
126199202 12619920 14 20160120 20150924 0
126199202 12619920 15 20160218 0
126199202 12619920 16 20160414 0